Summary of - traceability of counterfeit drugs in pharma supply chain through blockchain technology-a systematic review of the evidence

Document Type

Article

Abstract

Study Background: The research presented titled “ Traceability of counterfeit drugs in pharma supply chain through blockchain technology-a systematic review of the evidence “ by Dr. Adithya D. Shetty, Dr. Sandeep S. Shenoy, Dr. D. Sreedhar, Dr. Ankitha Shetty, Dr. Rohini Rao and Ms. Komal Jenifer D’souza justifies the role of blockchain by investigating the challenges and vulnerabilities in pharmaceutical logistics, including medication shortages, counterfeit products, and security risks. Through a comprehensive examination of the weaknesses in the pharma supply chain, the paper emphasizes the critical importance of this sector, where failures can have severe consequences, unlike any other industry.

Research goals and hypothesis: The primary goal of this study is to design a pharma supply chain based on blockchain technology that will help avoid drug counterfeiting by helping manufacturers and every subsequent link to keep track of their product while the consumers are enabled to trace back the parties involved with the particular drug.

Methodological approach: The study follows the PRISMA guidelines in order to synthesize the literature. This paper makes an honest attempt to discuss the glitches in the pharma supply chain due to faulty systems in place. It further deliberates on the need for the implementation of blockchain so as to enable a fool-proof track-and-trace system which goes on to avoid the occurrence of counterfeit drugs in the supply chain. The findings highlight the opportunities of blockchain in the area of pharma supply chain and how vital it is for future adoption and implementation.

Publication Date

2022

Link to Full Text

Share

COinS